These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 17972818)
21. New pharmacologic therapies in gastrointestinal disease. Wallace JL; Ferraz JG Gastroenterol Clin North Am; 2010 Sep; 39(3):709-20. PubMed ID: 20951926 [TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacology considerations in development of gastrohepatology products. Lee SC; Apparaju S; Kim I; Estes K; Jappar D; Bashaw ED Clin Pharmacol Ther; 2012 Sep; 92(3):281-3. PubMed ID: 22910484 [TBL] [Abstract][Full Text] [Related]
23. CCK1 antagonists: are they ready for clinical use? Peter SA; D'Amato M; Beglinger C Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265 [TBL] [Abstract][Full Text] [Related]
24. [Prokinetic drugs in gastroenterology]. Galmiche JP; Bruley des Varannes S; Le Bodic L Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903 [No Abstract] [Full Text] [Related]
25. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Camilleri M; Bueno L; de Ponti F; Fioramonti J; Lydiard RB; Tack J Gastroenterology; 2006 Apr; 130(5):1421-34. PubMed ID: 16678556 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological treatment of functional bowel disorders: any light at the end of the tunnel? Boeckxstaens GE Curr Opin Pharmacol; 2008 Dec; 8(6):669-70. PubMed ID: 18835367 [No Abstract] [Full Text] [Related]
27. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Pasricha PJ Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201 [No Abstract] [Full Text] [Related]
28. Therapy of gastrointestinal motility disorders: moving in the right direction. Kuemmerle JF Gastroenterologist; 1994 Jun; 2(2):166-73. PubMed ID: 8055241 [TBL] [Abstract][Full Text] [Related]
29. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587 [TBL] [Abstract][Full Text] [Related]
31. 5-hydroxytryptamine and the gastrointestinal migrating motor complex. Plaza MA Curr Opin Investig Drugs; 2001 Apr; 2(4):539-44. PubMed ID: 11566014 [TBL] [Abstract][Full Text] [Related]
36. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome. Camilleri M Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696 [No Abstract] [Full Text] [Related]
37. The potential of ghrelin as a prokinetic. Poitras P; Tomasetto C Regul Pept; 2009 Jun; 155(1-3):24-7. PubMed ID: 19362577 [TBL] [Abstract][Full Text] [Related]
38. Human colonic pharmacology. Bennett A Scand J Gastroenterol Suppl; 1984; 93():59-64. PubMed ID: 6145215 [TBL] [Abstract][Full Text] [Related]
39. Motilin and ghrelin as prokinetic drug targets. De Smet B; Mitselos A; Depoortere I Pharmacol Ther; 2009 Aug; 123(2):207-23. PubMed ID: 19427331 [TBL] [Abstract][Full Text] [Related]
40. [Prokinetic agents--their contribution to practice of gastroenterology]. Hep A; Dolina J Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]